Copper(II)Complexes of Pyrazolopyrimidine Derivativesas Anticancer Agents with Enhanced Chemodynamic Therapy through BimodalApoptosis and Ferroptosis

We reported 10 new copper­(II) complexes <b>1</b>–<b>10</b> with pyrazolopyrimidine derivatives as ligands. Complexes <b>2</b> and <b>4</b> reacted with glutathione (GSH) in cells through Fenton-like reaction to generate highly toxic hydroxyl radical (·OH) for chemodynamic therapy (CDT), and reduced endogenous glutathione peroxidase 4 (GPX4) to induce ferroptosis. In addition, these complexes effectively caused mitochondrial dysfunction and induced apoptosis and autophagy in tumor cells. Furthermore, <b>2</b> and <b>4</b> effectively inhibited the bladder cancer cell growth in a xenograft model. This study presents new copper­(II) complexes that can significantly induce bladder cancer cells death by enhanced CDT through bimodal apoptosis and ferroptosis, providing a promising approach for cancer therapy.